Below is a summary of the resolution passed. Complete resolution can be found on the company's website. The resolution was passed with the required majority.
Changes to the Board of directors
At the Extraordinary General Meeting of
This election a part of a strategic initiative as 2cureX refines its strategy to facilitate the implementation of IndiTreat® testing across individual hospitals. Such a move towards decentralization necessitates an enhancement of the company's expertise in technical and regulatory areas. Grith Hagel is poised to significantly contribute to the integration and adoption of the IndiTreat® platform within cancer hospitals due to her background and expertise.
As a co-founder of 2cureX and previously of BioImage, a company that evolved from
The Board of Directors hereafter consists of Tonny Bülow-Nielsen, Grith Hagel and Ole Thastrup.
Publication
The information was submitted for publication, through the agency of the contact persons set out below, at
Malmö in
Board of Directors
N.B. This English text is an unofficial translation of the Swedish original of the notice to attend the extraordinary general meeting in
© Modular Finance, source